1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Cardiovasculares

Enfermedades Cardiovasculares

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Hinojar R, Fernández-Golfín C, González-Gómez A, Rincón LM, Plaza-Martin M, Casas E, García-Martín A, Fernandez-Mendez MA, Esteban A, Nacher JJJ, Zamorano JL.

    Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 249: 467-472. Nº de citas: 40

    [doi:10.1016/j.ijcard.2017.07.087]

  • González Gómez A, Fernández-Golfín C, Monteagudo JM, Izurieta C, Hinojar R, García A, Casas E, Jiménez-Nacher JJ, Moya JL, Ruiz S, Zamorano JL.

    Severe aortic stenosis patients with preserved ejection fraction according to flow and gradient classification: Prevalence and outcomes.

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 248: 211-215. Nº de citas: 6

    [doi:10.1016/j.ijcard.2017.06.064]

  • Grande E, Glen H, Aller J, Argenziano G, Lamas MJ, Ruszniewski P, Zamorano JL, Edmonds K, Sarker S, Staehler M, Larkin J.

    Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma.

    EXPERT OPINION ON DRUG SAFETY . 16(12): 1413-1426. Nº de citas: 2

    [doi:10.1080/14740338.2017.1380624]

  • Antunes MJ, Rodríguez-Palomares J, Prendergast B, De Bonis M, Rosenhek R, Al-Attar N, Barili F, Casselman F, Folliguet T, Iung B, Lancellotti P, Muneretto C, Obadia JF, Pierard L, Suwalski P, Zamorano P, ESC Working Groups of Cardiovascular Surgery and Valvular Heart Disease.

    Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease.

    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY . 52(6): 1022-1030. Nº de citas: 86

    [doi:10.1093/ejcts/ezx279]

  • Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL, Nihoyannopoulos P, Edvardsen T, Lancellotti P, EACVI Scientific Documents Committee for 2014–16 and 2016–18, EACVI Scientific Documents Committee for 2014–16 and 2016–18.

    Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017.

    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING . 18(11): . Nº de citas: 101

    [doi:10.1093/ehjci/jex182]

  • Salido Tahoces L, Hernández Antolín RA, Zamorano Gómez JL.

    Aortic stenosis. Indications and results of percutaneous aortic valve implantation (TAVI).

    REVISTA CLINICA ESPANOLA . 217(8): 478-483.

    [doi:10.1016/j.rce.2017.05.001]

  • Chan J, Shiino K, Obonyo NG, Hanna J, Chamberlain R, Small A, Scalia IG, Scalia W, Yamada A, Hamilton-Craig CR, Scalia GM, Zamorano JL.

    Left Ventricular Global Strain Analysis by Two-Dimensional Speckle-Tracking Echocardiography: The Learning Curve.

    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY . 30(11): 1081-1090. Nº de citas: 49

    [doi:10.1016/j.echo.2017.06.010]

  • Quintanilla JG, Moreno J, Archondo T, Alfonso-Almazán JM, Lillo-Castellano JM, Usandizaga E, García-Torrent MJ, Rodríguez-Bobada C, González P, Borrego L, Cañadas-Godoy V, González-Ferrer JJ, Pérez-Castellano N, Pérez-Villacastín J, Filgueiras-Rama D.

    QRS duration reflects underlying changes in conduction velocity during increased intraventricular pressure and heart failure.

    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY . 130(Pt B): 394-403. Nº de citas: 6

    [doi:10.1016/j.pbiomolbio.2017.08.003]

  • Alonso Salinas GL, Sanmartin M, Pascual Izco M, Rincon LM, Pastor Pueyo P, Marco Del Castillo A, Garcia Guerrero A, Caravaca Perez P, Recio-Mayoral A, Camino A, Jimenez-Mena M, Zamorano JL.

    Frailty is an independent prognostic marker in elderly patients with myocardial infarction.

    CLINICAL CARDIOLOGY . 40(10): 925-931. Nº de citas: 31

    [doi:10.1002/clc.22749]

  • Hinojar R, Zamorano JL, Gonzalez Gómez A, Plaza Martin M, Esteban A, Rincón LM, Portugal JC, Jimenez Nácher JJ, Fernández-Golfín C.

    ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.

    CLINICAL CARDIOLOGY . 40(10): 853-860. Nº de citas: 9

    [doi:10.1002/clc.22735]

  • Habib G, Bucciarelli-Ducci C, Caforio ALP, Cardim N, Charron P, Cosyns B, Dehaene A, Derumeaux G, Donal E, Dweck MR, Edvardsen T, Erba PA, Ernande L, Gaemperli O, Galderisi M, Grapsa J, Jacquier A, Klingel K, Lancellotti P, Neglia D, Pepe A, Perrone-Filardi P, Petersen SE, Plein S, Popescu BA, Reant P, Sade LE, Salaun E, Slart RHJA, Tribouilloy C, Zamorano J, Reviewers: Victoria Delgado, Kristina Haugaa (EACVI Scientific Documents Committ.

    Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the Working Group on myocardial and pericardial diseases of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography.

    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING . 18(10): 1090-1121. Nº de citas: 58

    [doi:10.1093/ehjci/jex034]

  • Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E.

    T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic Sarcoidosis.

    Radiology . 285(1): 63-72. Nº de citas: 85

    [doi:10.1148/radiol.2017162732]

  • Barrios V, Escobar C, Prieto Valiente L, Lobos JM, Vargas-Ortega D, Polo J, Marin Montañés N.

    Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation.

    Blood Pressure . 26(5): 279-283. Nº de citas: 3

    [doi:10.1080/08037051.2017.1313094]

  • Sanmartín-Fernández M, Marzal-Martín D.

    Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice: Focus on Rivaroxaban in Stroke Prevention in Patients With Atrial Fibrillation.

    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS . 23(7): 711-724. Nº de citas: 1

    [doi:10.1177/1076029616668404]

  • Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL.

    2017 ESC/EACTS Guidelines for the management of valvular heart disease.

    EUROPEAN HEART JOURNAL . 38(36): 2739-2791. Nº de citas: 3398

    [doi:10.1093/eurheartj/ehx391]

  • Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Neumann FJ, Tarantini G, Zamorano JL, Vahanian A.

    SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve.

    EUROPEAN HEART JOURNAL . 38(36): 2717-2726. Nº de citas: 84

    [doi:10.1093/eurheartj/ehx294]

  • Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, Böhm M, Charron P, Elliott PM, Eriksson U, Felix SB, Garcia-Pavia P, Hachulla E, Heymans S, Imazio M, Klingel K, Marcolongo R, Matucci Cerinic M, Pantazis A, Plein S, Poli V, Rigopoulos A, Seferovic P, Shoenfeld Y, Zamorano JL, Linhart A.

    Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease.

    EUROPEAN HEART JOURNAL . 38(35): 2649-2662. Nº de citas: 89

    [doi:10.1093/eurheartj/ehx321]

  • Chambers JB, Prendergast B, Iung B, Rosenhek R, Zamorano JL, Piérard LA, Modine T, Falk V, Kappetein AP, Pibarot P, Sundt T, Baumgartner H, Bax JJ, Lancellotti P.

    Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint.

    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY . 52(3): 418-424. Nº de citas: 10

    [doi:10.1093/ejcts/ezx283]